Optimal Compound Downselection To Promote Diversity and Parallel Chemistry.

Area of Science:

• Medicinal Chemistry
• Computational Chemistry
• Drug Discovery

Background:

• Early-stage drug discovery relies on iterative design-make-test cycles.
• Selecting compounds for synthesis involves complex decisions with multiple factors.

Purpose of the Study:

• To extend the SPARROW algorithmic downselection framework for compound selection.
• To incorporate synthesis failure risk, molecular diversity, and parallel chemistry capabilities into compound selection.

Main Methods:

• Building upon the existing SPARROW framework.
• Integrating additional critical factors into the algorithmic selection process.
• Applying the enhanced SPARROW formulation to a case study.

Main Results:

• The enhanced SPARROW framework captures more complex decision-making principles.
• It aligns algorithmic compound selection with expert chemist intuition.
• Demonstrated ability to select diverse compound batches suitable for parallel synthesis.

Conclusions:

• The extended SPARROW framework offers a more comprehensive approach to compound selection in drug discovery.
• This method aids in selecting diverse and synthesizable compound libraries.
• Improves efficiency and success rates in early-stage molecular design.